Summary & Overview
CPT 21034: Resection of Malignant Tumor of Maxilla or Zygoma
CPT code 21034 denotes open surgical excision of a malignant tumor of the maxilla or zygoma, using either an intraoral or extraoral approach. This code captures major oncologic resections of the upper jaw or cheekbone and is relevant to surgical oncology, otolaryngology, oral and maxillofacial surgery, and hospital billing workflows. Nationally, accurate coding for extensive craniofacial tumor resections affects claims routing, case mix reporting, and facility and professional payment for complex head and neck cancer care.
Key payers in most analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, the typical sites of service, and the common payer landscape. The publication outlines coding interpretation, relevant service mapping, and benchmarking considerations for facility and professional lines. It also highlights policy and documentation issues that commonly influence adjudication and reimbursement for major craniofacial oncologic resections.
This summary is written for a national audience of billing managers, surgical providers, and policy analysts seeking a clear description of the procedure, payer coverage scope, and what to expect when handling claims involving CPT code 21034.
Billing Code Overview
CPT code 21034 describes the open surgical removal of a malignant tumor of the maxilla (upper jaw bone) or the zygoma (cheekbone). The procedure may be performed via an intraoral approach through the mouth or an extraoral approach through the skin, depending on tumor location, extent, and surgeon preference.
Service Type: Open surgical tumor resection (oncologic surgery)
Typical Site of Service: Hospital operating room or ambulatory surgical center, depending on case complexity and patient needs.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents with a rapidly enlarging, painful mass of the left maxilla and cheek with associated nasal obstruction and loosening of adjacent teeth. Imaging (CT/MRI) demonstrates a destructive lesion of the maxilla with cortical breach and involvement of the zygoma. Biopsy confirms a malignant neoplasm of the maxillary sinus/upper jaw. The surgical team—usually an oral and maxillofacial surgeon or head and neck surgeon—plans an open maxillectomy with possible partial resection of the zygoma. The procedure may be performed via an intraoral approach if the tumor is accessible through the mouth, or via an extraoral approach (e.g., Weber-Ferguson incision) when wider access and margins are required. Preoperative workflow includes staging, multidisciplinary tumor board review, anesthesia evaluation, and consent for possible neck dissection or free flap reconstruction. Intraoperative steps include tumor extirpation with clear margins, hemostasis, possible resection of adjacent structures, and immediate reconstruction or obturator placement as indicated. Postoperative care includes inpatient monitoring for airway compromise, wound care, pain control, pathology review of margins, coordination with medical oncology and radiation oncology for adjuvant therapy, and staged dental or prosthetic rehabilitation as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, and effort significantly exceed typical for the procedure (extensive resection, complex reconstruction). |